Swiss firm Clariant sells Indian units for Rs 3,029 cr
Dec 27 2012 , New Delhi
Clariant Chemicals (India), part of Swiss specialty chemical giant Clariant, also sold its research and development centre, sales and marketing wing, production plants and sites to private investment firm SK Capital, which focuses on the specialty materials, chemicals and healthcare sectors.
“The total consideration of the sale amounts to approximately 502 million Swiss Francs, out of which approximately 460 million Swiss Francs will be paid in cash. This is equivalent to 6.3 times the estimated full-year 2012 recurring Ebitda of the businesses. The divestment has been approved by the boards of both the companies,” Clariant said in a statement on its website.
Subject to regulatory approvals, the transaction is expected to close by the end of the second quarter of 2013, it added.
In a filing to the Bombay Stock Exchange (BSE), Clariant Chemicals (India) said, “SK Capital has agreed to purchase the textile chemicals, paper specialties and the business line emulsions units from Clariant.”
This will include the transfer of the whole research and development, applications, sales and marketing organisation along with production plants and sites worldwide, it added.
Clariant Chemicals (India) has production facilities for manufacturing textile chemicals, paper specialties and emulsion products at its Roha (Maharashtra) plant.
The company is into specialty chemicals and is a leading player in pigments, textile chemicals, leather chemicals and biocides for paints in India.
It had reported net sales of Rs 267.08 crore and net profit of Rs 16.75 crore for the quarter ended September 30, 2012.
At present, S K Capital is investing from S K Capital Partners III, LP -- a $500 million fund of committed capital -- and is located in the US at New York and Boca Raton, Florida.
Shares of Clariant Chemicals (India) on Thursday rose by 2.01 per cent to settle at Rs 635.25 apiece from its previous close at the BSE.